Parul institute of Pharmacy & Research

Dr. Jagdish L. Kakadiya

Dr.-Jagdishbhai-Kakadiya
Designation : Associate Professor
Total Exp : 8 Years
Educational Qualification : M.Pharm., Ph.D.
Research Area :
Diabetes and its complications, Myocardial and Renal Ischemia/Reperfusion Injury and its complications (Clinical and Preclinical Study)

Dr Jagdish L Kakadiya is an academician and researcher in the domain of Pharmacy since more than 8 years. He has completed his PhD degree from JNU. He has secured his M.Pharm (The M. S. University, Baroda) and B.Pharm. (L. M. College of Pharmacy, Ahmedabad) degree in year 2009 and 2005. He has also qualified GATE in 2007 (All India 23th Rank). He is currently working as associate professor in pharmacology at Parul Institute of Pharmacy and Research, Parul University. He has not only the experience in the teaching field but has the experience of working as the ACPC nodal officer and as an examination coordinator. He is CPCSEA Nominee in many academic institutes and industries. Apart from this he has the technical experience in conducting experiments like Myocardial and Renal Ischemia/Reperfusion Injury (In Vivo) etc. He has been into handling of instruments like Student Biopac data acquisition system (MP30) and Physiograph etc. He has published more than 22 research and review papers in national & international UGC approval journals. More than 15 UGC Approval Journals, He is including as Editor board Member, Chief Editor or Advisory board member or Reviewer. He has also presented several papers in national & international conferences. He has 7 h-index and 4 i10 Index in Google Scholar.

Contact Information
Office Phone09825882922
Email[email protected]
Membership
-
Specialization
Specialization AreasDiabetes and its complications, Myocardial and Renal Ischemia/Reperfusion Injury and its complications (Clinical and Preclinical Study)

[1] Role of Neprilysin inhibitors combinations in cardiovascular disease. World Journal of Pharmaceutical Research 2016; 5(5): 1805-1812.

[2] Protective Effect of Hesperidine on cardiovascular complication in experimentally induced myocardial infarction in diabetic rats. Journal of basic and clinical pharmacy 2010; 1(2): 85-189.

[3] Effect of Glimepiride on cardiovascular complication in diabetes – An experimentally study in rats. International journal of pharma Research and development 2010; 2(3): 1-9.

[4] Effect of Hesperidine on Serum Glucose, HbA1c and Oxidative stress in myocardial tissue in experimentally induced myocardial infarction in diabetic rats. Pharmacognosy Journal 2010; 2(7): 185-189.

[5] Glimepiride reduces on experimentally induced ischemia/reperfusion in diabetic rats. International journal of applied biology and pharmaceutical technology 2010; 1(2): 276-285.

[6] Effect of Hesperidin on cardiovascular complication in Streptozotocin – Nicotinamide induced type 2 diabetic rats. International Journal of Pharmacy and Pharmaceutical Sciences 2010; 2(3): 165-169.

[7] Investigation effect of Glimepiride on Diabetic marker and cardiac lipid parameter in Isoproterenol induced myocardial infarction in diabetic rats. International Journal of Advances in Pharmaceutical Sciences 2010; 1(3): 319-335.

[8] Effect of Pioglitazone, Glimepiride, Nebivolol, Valsartan and Hesperidine on Serum Diabetic marker and lipid metabolizing enzymes in isoproterenol induced myocardial infarction in normal and diabetic rats. International journal of research in pharmaceutical sciences 2010; 1(2): 158-162.

[9] Effect of Nebivolol on serum diabetic marker and lipid profile in normal and Streptozotocin-Nicotinamide induced diabetic rats. Research journal of pharmaceutical, biological and chemical sciences 2010; 1(2): 329-334.

[10] Development and Validation of High Performance Thin Layer Chromatographic method for simultaneous estimation of Levosulpiride and Esomeprazole in combined pharmaceutical formulation. World Journal of Pharmacy and Pharmaceutical Sciences 2014; 3(5): 1621-1636.

[11] In vitro antioxidant in heart of Pioglitazone on isoproterenol induced myocardial infarction in normal and type 2 diabetic rats. Research journal of pharmaceutical, biological and chemical sciences 2010; 1(2): 131-136.

[12] Development and validation of dual wavelength UV Spectrophotometric method for simultaneous estimation of Ambroxol hydrochloride and Cefpodoxime proxetile in their combined Tablet dosage form. International Research Journal of Pharmacy 2012; 3(4): 330-333.

[13] Renal Function Markers: A Short Review. Journal of innovative trends in pharmaceutical science 2010; 1(6): 270-273.

[14] Effect of Valsartan on isoproterenol induced myocardial infarction and histopathological in heart in diabetic rats. Research journal of pharmaceutical, biological and chemical sciences 2010; 1(2): 275-283.

[15] Development and Validation of HPLC Method for the Simultaneous Estimation of Levosulpiride and Esomeprazole in their Combined Pharmaceutical Dosage Formulation. Asian Journal of Pharmaceutical Technology & Innovation 2014; 2(6): 01-12.

[16] RP- HPLC Method Development and Validation For Simultaneous Estimation Of Ambroxol Hydrochloride And Cefpodoxime Proxetile In Pharmaceutical Dosage Form. American journal of Pharmtech Research 2012; 2(3): 1043-1052.

[17] Cardiovascular complications of diabetes – Review. Pharmacologyonline 2010; 1: 1-10.

[18] Involvement of free radicals in cardiovascular complication in type 2 diabetes – A review. Pharmacologyonline 2009; 3: 862-886.

[19] Effect of Glimepiride on Oxidative stress in heart – A Experimentally induced myocardial infarction in diabetic rats. Pharmacologyonline 2010; 1: 160-166.

[20] Effect of Metformin alone and alone with Pioglitazone on hepatic functions in diabetic rats. Pharmacologyonline 2009; 1: 1163-1172.

[21] Renoprotective activity of Pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats. Recent Research in Science and Technology 2010, 2(3): 92-97.

[22] Kidney damage induced renal ischamia/reperfusion injury in Sprague dawley diabetic rats. Pharmacologyonline 2011; 1: 1045-1058.

[23] Development and validation of first order derivative Spectrophotometric method for simultaneous estimation of Ambroxol and Cefpodoxime in combined tablet dosage form. International Journal of Pharmaceutical and Chemical Sciences 2012; 1(2): 717-722.

[24] Protective effect of Glimepiride alone and its combination with Metformin on serum glucose, HbA1c and liver functions in nondiabetic and diabetic rats. Pharmacologyonline 2009; 2: 261-272.